Pfizer Diflucan Partnership Program [3] (multiple letters)

Lancet

Volumn 361, Issue 9351, 2003, Pages 72-

  Sebati, Konji ^a   Henry, David ^b   Lexchin, Joel ^c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

AFRICA; BOTSWANA; CANDIDIASIS; CRYPTOCOCCUS; DEVELOPING COUNTRY; DRUG INDUSTRY; ERROR; GOVERNMENT; HEALTH CARE FACILITY; LESOTHO; LETTER; MEDICAL LITERATURE; MENINGITIS; PRIORITY JOURNAL; SOUTH AFRICA; SWAZILAND;

EID: 0037417539     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12124-1     Document Type: Letter

References (1)

1. Henry D Lexchin J The pharmaceutical industry as a medicines provider Lancet 360 2002 1590 1595